Drug Profile
Pneumococcal vaccine surface protein A
Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 01 May 1997 New profile
- 01 May 1997 Preclinical development for Pneumococcal infections in USA (Intranasal)